21 CFR Part 11 is a regulation established by the U.S. Food and Drug Administration (FDA) that sets the guidelines for the use of electronic records and electronic signatures in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries. 21 CFR Part 11 typically applies to companies operating in the United States. This page offers a brief overview of technical functionalities that satisfy 21 CFR Part 11 requirements and support implementation within an organisation. It does not delve into comprehensive details of 21 CFR Part 11 or serve as legal counsel for achieving absolute compliance. The page below summarises the relevant sections of 21 CFR Part 11 related to electronic systems and highlights how Seal implements these technical mandates.

Subpart B - Electronic Records

Subpart C - Electronic Signatures